For the first time, doctors have used a CRISPR gene editing therapy in an attempt to fix broken genes within the body, marking another step forward for a technology that promises to change how some inherited diseases are treated.
Clinicians at Oregon Health and Science University recently injected the therapy, developed by biotech Editas Medicine and partner Allergan, into the eye of a patient with a type of severe blindness, the companies confirmed Wednesday.
A study last year tested another CRISPR medicine in stem cells extracted from patients' blood, while a third trial previously used a different type of gene editing technology called zinc finger nucleases inside the body. But the patient recently given Editas and Allergan's therapy is the first to be treated using a CRISPR therapy that works in vivo.
The eye disease the companies hope to correct, called Leber cogenital amaurosis, is caused by mutations in any of at least a dozen genes. Editas and Allergan are focusing on just one particular type, known as LCA10. Between 2,000 and 5,000 patients in the U.S. and Europe have it, according to the companies.
"Half of the patients who have this disease are born essentially with light perception vision. They can tell that the room is dark or light," said Mark Pennesi, an associate professor of ophthalmology who is leading OHSU's involvement in the study, in an interview.
"The other half start at legal blindness and then will degrade over the first two decades of life."
Pennesi and his colleagues hope Editas and Allergan's medicine could restore vision by deleting the mutation that prevents the eye from making a protein critical to light-detecting cells.
If that protein is made again, the damaged segment of those photoreceptors should be able to regenerate, said Charles Albright, chief scientific officer at Editas, in an interview last month.
Editas and Allergan plan to enroll 18 adults and children into the study, which is currently being conducted at OHSU as well as centers in Miami, Boston and Ann Arbor, Michigan.
The initial focus will be on safety, as researchers gauge whether the CRISPR medicine being tested causes any side effects or toxicities. Should all go well with the first few adults given a low dose, Editas and Allergan will test four higher doses and potentially try the therapy in children.
Enrolling patients into the study, dubbed BRILLIANCE, has taken longer than the companies first expected when they opened the trial last July.
"Getting patients enrolled and recruiting has taken longer than planned," said Albright, noting there were prospective study participants who came in but ultimately weren't eligible for dosing.
Moving forward, Albright said enrollment should proceed more smoothly.
Whether the treatment helps improve vision will be measured using eye charts and a "mobility maze" similar to one used by Spark Therapeutics for its gene therapy Luxturna, approved in late 2017 for a different type of inherited blindness.
Luxturna works not by editing DNA, but rather by inserting a functional copy of a defective gene directly into the eye. That approach wasn't possible with LCA10, Pennesi said, because the gene in question is too large to fit into the inactivated viruses companies are using as delivery vehicles.
Editing DNA holds potential risks, however the greatest being that the CRISPR therapy inadvertently cuts DNA in places the companies and researchers don't intend and makes irreversible changes.
As with all firsts, the long-term effects of gene editing aren't known either, although Albright noted that photoreceptor cells in the eye no longer divide, potentially making the results of Editas and Allergan's therapy more predictable.
While Editas and Allergan are first to the milestone of in vivo CRISPR editing, the field around them is quickly advancing.
CRISPR Therapeutics and Vertex, which are running the study that used a CRISPR therapy on extracted stem cells, already have initial data, while rival Intellia Therapeutics plans to begin this year a study of in vivo CRISPR editing in a rare disease known as transtheyretin amyloidosis.
Other, newer companies, meanwhile, are working to move past CRISPR and into more specific types of gene editing. One, the Cambridge, Massachusetts-based Beam Therapeutics, recently raised $207 million on the promise of its base-editing platform.
But the studies run by CRISPR Therapeutics and Editas, being the first in their respective settings, will be watched close.
"These are setting precedent," said Albright. "You're going to be seeing a lot more gene editing."
See the original post:
In a CRISPR first, Editas therapy used to fix genes in the body - BioPharma Dive
- New drug candidate uses novel absorption method to target cancer cells in mice - Michigan Medicine - August 22nd, 2022
- Jianping Fu Mechanical Engineering - University of Michigan - July 11th, 2022
- Cell Culture Market Key Drives Zeroing In On The Main Merchants | Danaher Corporation, Thermo Fisher Scientific Designer Women - Designer Women - July 11th, 2022
- Erasing The Stigma Of Sickle Cell Disease Through Advocacy - Essence - June 22nd, 2022
- This One Group Of People Holds The Key To Staying Young, Study Says Eat This Not That - Eat This, Not That - May 2nd, 2022
- Primary Cells Market 2022 is set to experience a significant growth rate | PromoCell GmbH, HemaCare Corporation, Thermo Fisher Scientific ... - May 2nd, 2022
- 3D Cell Culture Market to 2030 | Industry Statistics, Emerging Demands, Forecast to 2030 | 3D Biotek, LLC Advanced Biomatrix, Inc. Becton, Dickinson... - May 2nd, 2022
- Oral Cavity | histology - University of Michigan - April 19th, 2022
- Unraveling Stem Cells' Secrets: Immortality of Germline Cells and the Function of Junk DNA - SciTechDaily - April 19th, 2022
- Scientists De-Aged a Woman's Skin Cells by 30 Years - The Daily Beast - April 19th, 2022
- Longboat residents recall the greatest gifts - YourObserver.com - December 24th, 2021
- Nebraska Athletics News: Recruiting Season, Living Robots and Stuck in IKEA - Corn Nation - December 10th, 2021
- Duke Faculty Promoted or Appointed to the Rank of Full Professor - Duke Today - November 8th, 2021
- Lab-Growing Everything Might Be The Only Way To Attain A Sustainable World - Intelligent Living - November 8th, 2021
- Male Infertility Could Be Treated With Monkey Cells; New Study Shows How These Animals Could Help Address the Condition - Science Times - October 28th, 2021
- Insights & Outcomes: Place cells, planarians, and 'prewet' proteins - Yale News - October 28th, 2021
- Using a mini heart model to develop new therapies - MSUToday - October 5th, 2021
- Rowan University hosts National Science Foundation research program for undergrads - Rowan Today - August 31st, 2021
- Loss of a top autism gene may alter neuron structure - Spectrum - January 17th, 2021
- Rogel team receives $11.2M to leverage the microbiome against GVHD - Newswise - October 28th, 2020
- Latest Update 2020: What Are the Key Players Evolving In the Growth of the 3D Cell Culture Market? - re:Jerusalem - October 28th, 2020
- Listings - CON, THE on ABC | TheFutonCritic.com - The Futon Critic - October 15th, 2020
- ABC News Debuts New Primetime Series THE CON Narrated by Whoopi Goldberg - Broadway World - October 8th, 2020
- HOME GROWN: Pumpkins best left on the vine for as long as possible - The Oakland Press - October 8th, 2020
- Official Missteps in Michigan's Worst Covid Prison Outbreak - The Intercept - September 29th, 2020
- Regenerative medicine and war: The next breakthrough in treating injured veterans? - Genetic Literacy Project - September 29th, 2020
- Hematopoietic Stem Cells (HSCs) Market Primary Research, Secondary Research, Product Research, Trends And Forecast By 2026- Kite Pharma Inc., Thermo... - September 29th, 2020
- New research connects the hormones we're born with to lifetime risk for immunological diseases - MSUToday - September 20th, 2020
- School of Science grows by 10 - MIT News - September 10th, 2020
- COVID-19 Drug Discovery and Development Why Diverse Strategies Are Critical - Technology Networks - September 10th, 2020
- Researchers identify environmental components that affect gene expression in cardiovascular disease - The South End - June 21st, 2020
- Hesperos Human-on-a-Chip used to model Alzheimer's and MCI - SelectScience - June 2nd, 2020
- Are immune-compromised kids at greater risk from Covid-19? - Health24 - May 3rd, 2020
- Erika Hersch-Green Wins CAREER Award for Biodiversity Research - Michigan Tech News - May 2nd, 2020
- Science Becomes A Dividing Issue In Year Of Election And Pandemic - Michigan Radio - May 2nd, 2020
- Stopping Smoking Allows Healthy Lung Cells to Proliferate - Medscape - February 8th, 2020
- After a bone injury, shape-shifting cells rush to the rescue - University of Michigan News - January 29th, 2020
- Engineer the future of human health with a PhD in biomedical engineering - Study International News - January 29th, 2020
- The Unexpected Diversity of Pain - Scientific American - January 24th, 2020
- BREAKING: A woman gives birth to the Son of God (Part II) - INQUIRER.net - January 5th, 2020
- Collaborative Robots: Rai... - Robotics Online - December 19th, 2019
- VetStem Biopharma Shares the Success Story of Jesse Who was Treated with VetStem Cell Therapy - PR Web - December 8th, 2019
- Stem Cell Therapy Michigan | Regenerative Medicine 248-216 ... - February 27th, 2019
- Stem Cell Treatments Bloomfield Hills, MI | 248-216-1008 - January 9th, 2019
- Michigan Integrative Health Dr. Roy Picard, D.C. - December 27th, 2018
- Breast Cancer Stem Cells Stopping Them In Their Tracks ... - November 23rd, 2018
- Stem Cell Treatments MI | Michigan Center for Renerative ... - November 2nd, 2018
- Michigan Stem Cell Therapy - Foot HealthCare Associates - November 2nd, 2018
- Cancer Stem Cell Research | University of Michigan Rogel ... - November 2nd, 2018
- University of Michigan Stem Cell Research | Treatment and ... - November 2nd, 2018
- Detroit Michigan Stem Cell Therapy - americanregen.com - September 28th, 2018
- Combination of traditional chemotherapy, new drug kills ... - September 4th, 2018
- Stem Cells FAQ Michigan Stem Cell Institute - August 29th, 2018
- Anti-Aging, Regeneration and Stem Cell Supplements - August 7th, 2018
- Families raise money for research into rare diseases - KARE - September 8th, 2017
- Cells that stand in the way of HIV cure: Discovery expands understanding of marrow's role - Medical Xpress - August 5th, 2017
- Turmeric and black pepper fight cancer stem cells - November 26th, 2016
- Michigan company mines stem cells in search of Fountain of ... - November 18th, 2016
- stem cell research | Michigan Radio - October 6th, 2016
- Stem Cell Therapy Treatment at Allure Medical Spa in Michigan - October 6th, 2016
- University of Michigan Stem Cell Research | Experts List - September 20th, 2016
- Five years after Michigan vote on human embryonic stem ... - August 26th, 2016
- Scientists coax stem cells to form 3-D mini lungs ... - August 11th, 2016
- Cancer stem cells - University of Michigan Comprehensive ... - July 25th, 2016
- Michigan Catholic Conference: Home - October 19th, 2015
- Michigan Stem Cell Amendment, Proposal 2 (2008 ... - July 2nd, 2015
- University of Michigan Stem Cell Research | Embryo Donation - May 12th, 2015
- University of Michigan Stem Cell Research | Stem Cell ... - April 22nd, 2015
- How to grow a human lung - March 25th, 2015
- Novogen (NVGN) Promising Data in Brain Cancer; eFuture Information Technology (EFUT) and ... - March 5th, 2015
- Stem Cell Research - Right to Life of Michigan - February 24th, 2015
- Breast Cancer Stem Cell Research - University of Michigan ... - January 17th, 2015
- What makes pancreatic cancer so aggressive? New study sheds light - January 16th, 2015
- Leukemia Stem Cell Research | University of Michigan ... - January 4th, 2015
- Seeing Is Believing - December 12th, 2014
- Swiston receives Commitment to Education Award - November 29th, 2014
- Bone marrow registration drive to be held at Saint Mary's College - November 18th, 2014
- Researchers devise a means for growing near 2-D chemical gardens (w/ Video) - November 11th, 2014
- Stem cells help doctors restore womans smile, regenerating bone to hold dental implants - November 5th, 2014
- Reason to Bree-Lieve: Greenville girl continues to beat the odds - November 5th, 2014